Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-28T17:54:51.244Z Has data issue: false hasContentIssue false
  • English
  • Français

Sustained Savings from a Longitudinal Cost Analysis of an Internet-Based Preapproval Antimicrobial Stewardship Program

Published online by Cambridge University Press:  02 January 2015

Anna C. Sick ,
Christoph U. Lehmann ,
Pranita D. Tamma ,
Carlton K. K. Lee  and
Allison L. Agwu
Anna C. Sick
Affiliation:
Johns Hopkins University School of Medicine, Baltimore, Maryland
Christoph U. Lehmann
Affiliation:
Departments of Pediatrics and Biomedical Informatics, Vanderbilt University, Nashville, Tennessee
Pranita D. Tamma
Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
Carlton K. K. Lee
Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Pharmacy, Johns Hopkins Hospital, Baltimore, Maryland
Allison L. Agwu*
Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
*
Department of Pediatrics, Division of Pediatric Infectious Diseases, and Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Room 3145, Baltimore, MD 21287 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To evaluate an internet-based preapproval antimicrobial stewardship program for sustained reduction in antimicrobial prescribing and resulting cost savings.

Design.

Retrospective cohort study and cost analysis.

Methods.

Review of all doses and charges of antimicrobials dispensed to patients over 6 years (July 1, 2005–June 30, 2011) at a tertiary care pediatric hospital.

Results.

Restricted antimicrobials account for 26% of total doses but 81% of total antimicrobial charges. Winter months (November–February) and the oncology and infant and toddler units were associated with the highest antimicrobial charges. Five restricted drugs accounted for the majority (54%) of charges but only 6% of doses. With an average approval rate of 91.5% (95% confidence interval [CI], 91.1%–91.9%), the preapproval antibiotic stewardship program saved $103,787 (95% CI, $98,583–$109,172) per year, or $14,156 (95% CI, $13,446–$14,890) per 1,000 patient-days.

Conclusions.

A preapproval antimicrobial stewardship program effectively reduces the number of doses and subsequent charges due to restricted antimicrobials years after implementation. Hospitals with reduced resources for implementing postprescription review may benefit from a preapproval antimicrobial stewardship program. Targeting specific units, drugs, and seasons may optimize preapproval programs for additional cost savings.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 34 , Issue 6 , June 2013 , pp. 573 - 580
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.SHEA, IDSA, PIDS. Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012;33(4):322–327.CrossRefGoogle Scholar
2.Tamma, PD, Cosgrove, SE. Antimicrobial stewardship. Infect Dis Clin N Am 2011;25(1):245–260.Google Scholar
3.Doron, S, Davidson, LE. Antimicrobial stewardship. Mayo Clin Proc 2011;86(11):1113–1123.Google Scholar
4.Dellit, TH, Owens, RC, McGowan, JE, et al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44(2): 159–177.Google Scholar
5.Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pépin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45(suppl 2):S112–S121.CrossRefGoogle ScholarPubMed
6.Pear, SM, Williamson, TH, Bettin, KM, Gerding, DN, Galgiani, JN. Decrease in nosocomial Clostridium difficile–associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120(4): 272–277.Google Scholar
7.Climo, MW, Israel, DS, Wong, ES, et al.Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile–associated diarrhea and cost. Ann Intern Med 1998;128(12):989–995.Google Scholar
8.Moleski, RJ, Andriole, VT. Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis 1986;8(3):488–493.Google Scholar
9.Seligman, SJ. Reduction in antibiotic costs by restricting use of an oral cephalosporin. Am J Med 1981;71(6):941–944.Google Scholar
10.Woodward, RS, Medoff, G, Smith, MD, Gray, JL III. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 1987;83(5):817–823.Google Scholar
11.Sáez-Llorens, X, Wong, MMC, Castaño, E, de Suman, O, de Moros, D, de Atencio, I. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. Pediatr Infect Disease J. 2000;19(3):200–206.Google Scholar
12.Ozkurt, Z, Erol, S, Kadanali, A, Ertek, M, Ozden, K, Tasyaran, MA. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists. Jpn J Infect Dis 2005;58(6):338–343.Google ScholarPubMed
13.White, AC JrAtmar, RL, Wilson, J, Cate, TR, Stager, CE, Greenberg, SB. Effects of requiring prior authorization for selected anti-microbials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25(2):230–239.Google Scholar
14.Recco, RA, Gladstone, JL, Friedman, SA, Gerken, EH. Antibiotic control in a municipal hospital. JAMA 1979;241(21):2283–2286.Google Scholar
15.Agwu, AL, Lee, CKK, Jain, SK, et al.A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis 2008;47(6):747–753.CrossRefGoogle Scholar
16.Hersh, AL, Beekmann, SE, Polgreen, PM, Zaoutis, TE, Newland, JG. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol 2009;30(12):1211–1217.Google Scholar
17.Johannsson, B, Beekmann, SE, Srinivasan, A, et al.Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infection Control Hosp Epidemiol 2011;32(4):367–374.CrossRefGoogle ScholarPubMed
18.Coleman, RW, Rodondi, LC, Kaubisch, S, Granzella, NB, O'Hanley, PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J Med 1991;90(4):439–444.Google Scholar
19. Maryland Health Services Cost Review Commission, http://www.hscrc.state.md.us/index.cfm.Google Scholar
20.Miller, MR, Elixhauser, A, Zhan, C. Patient safety events during pediatric hospitalizations. Pediatrics 2003;111(6):1358–1366.CrossRefGoogle ScholarPubMed
21. StataCorp. Stata Statistical Software, release 12. College Station, TX: StataCorp; 2011.Google Scholar
22.Metjian, TA, Prasad, PA, Kogon, A, Coffin, SE, Zaoutis, TE. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 2008;27(2):106–111.Google Scholar
23.Standiford, HC, Chan, S, Tripoli, M, Weekes, E, Forrest, GN. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol 2012;33(4):338–345.Google Scholar
24.Beardsley, JR, Williamson, JC, Johnson, JW, Luther, VP, Wrenn, RH, Ohl, CC. Show me the money: long-term financial impact of an antimicrobial stewardship program. Infect Control Hosp Epidemiol 2012;33(4):398–400.Google Scholar
25.Lau, BD, Pinto, BL, Thiemann, DR, Lehmann, CU. Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake. Clin Ther 2011;33(11): 1792–1796.Google Scholar
26.Lehmann, CU, Kim, GR. Prevention of medication errors. Clin Perinatol 2005;32(1):107–123.Google Scholar
27.Ohl, CA, Dodds Ashley, ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis 2011;53(suppl 1):S23–S28.Google Scholar
28.Sunenshine, RH, Liedtke, LA, Jernigan, DB, Strausbaugh, LJ. Role of infectious diseases consultants in management of antimicrobial use in hospitals. Clin Infect Dis 2004;38(7):934–938.Google Scholar